共 50 条
Impact of Magnetic Resonance Imaging on Cardiac Mortality in Thalassemia Major
被引:42
|作者:
Chouliaras, Giorgos
[1
]
Berdoukas, Vasilios
[1
]
Ladis, Vassilis
[1
]
Kattamis, Antonis
[1
]
Chatziliami, Antonia
Fragodimitri, Christina
Karabatsos, Fotis
Youssef, Jacqueline
Karagiorga-Lagana, Markissia
机构:
[1] Univ Athens, Thalassaemia Unit, Dept Paediat 1, Aghia Sophia Childrens Hosp, Athens 11527, Greece
关键词:
thalassemia major;
cardiac death;
magnetic resonance imaging (MRI);
iron overload;
iron chelation therapy;
MYOCARDIAL IRON;
COMBINED THERAPY;
HEART-FAILURE;
DEFEROXAMINE;
DEFERIPRONE;
SURVIVAL;
COMPLICATIONS;
TRANSFUSION;
MORBIDITY;
REGIMES;
D O I:
10.1002/jmri.22621
中图分类号:
R8 [特种医学];
R445 [影像诊断学];
学科分类号:
1002 ;
100207 ;
1009 ;
摘要:
Purpose: To evaluate whether the introduction of magnetic resonance imaging (MRI) in the management of thalassemia major (TM) patients has affected the risk of cardiac death. Materials and Methods: In all, 804 TM patients from two large reference units were included and the risk of dying of cardiac causes, before and after their first MRI, was assessed by a Cox proportional hazards model with time-dependent covariates. Results: Adding information from MRI reduced the risk of cardiac death from 6.0 deaths/1000 patient-years to 3.9 deaths/1000 patient-years (P = 0.22). The risk of cardiac death before having an MRI study was 82% higher compared to the risk observed after the first MRI. Conclusion: MRI has become a vital component of ongoing management and seems to have a beneficial effect on cardiac mortality in TM.
引用
收藏
页码:56 / 59
页数:4
相关论文